Boing Alexandra Crispim, Bertoldi Andréa Dâmaso, Boing Antonio Fernando, Bastos João Luiz, Peres Karen Glazer
Programa de Pós-graduação em Saúde Coletiva, Universidade Federal de Santa Catarina, Florianópolis, Brasil.
Cad Saude Publica. 2013 Apr;29(4):691-701.
This study aimed to describe the prevalence of access to medicines in the Brazilian Unified National Health System and associated factors among patients that received prescriptions in the public system. The study analyzed data from the National Household Sample Survey (2008). The sample consisted of individuals with prescriptions written in the National Health System in the two weeks prior to the interview (n = 19,427). The dependent variable was access to all the prescribed medicines inside the system itself. Slightly fewer than half of the sample with prescriptions received the medicines in the public health system; the proportions were higher in the South of Brazil, among black patients, those with less schooling and lower income, and those registered in the Family Health Strategy. When analyzing prescriptions written by the private sector, access to all the prescribed drugs was associated with higher income, higher education, and white skin color. The results emphasize the need for policies to decrease inequalities in access to medicines in Brazil.
本研究旨在描述巴西统一国家卫生系统中获得药品的情况以及在公共系统中接受处方的患者的相关因素。该研究分析了全国家庭抽样调查（2008年）的数据。样本包括在访谈前两周内在国家卫生系统开具过处方的个人（n = 19427）。因变量是在系统内部获得所有处方药品的情况。略少于一半的有处方样本在公共卫生系统中获得了药品；在巴西南部、黑人患者、受教育程度较低和收入较低的人群以及家庭健康战略登记的人群中，这一比例较高。在分析私营部门开具的处方时，获得所有处方药与较高收入、较高教育程度和白人肤色相关。结果强调了巴西需要制定政策来减少获得药品方面的不平等现象。
